BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6583274)

  • 1. Dietary management of Type I glycogen storage disease.
    Folk CC; Greene HL
    J Am Diet Assoc; 1984 Mar; 84(3):293-8, 301. PubMed ID: 6583274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous nocturnal intragastric feeding for management of type 1 glycogen-storage disease.
    Greene HL; Slonim AE; O'Neill JA; Burr IM
    N Engl J Med; 1976 Feb; 294(8):423-5. PubMed ID: 813144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three consecutive pregnancies in a patient with glycogen storage disease type IA (von Gierke's disease).
    Ryan IP; Havel RJ; Laros RK
    Am J Obstet Gynecol; 1994 Jun; 170(6):1687-90; discussion 1690-1. PubMed ID: 8203427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two different anesthetic managements of a patient with von Gierke's disease.
    Huang IR; Jean WH; Lu CW; Wu CC; Lin TY; Chuang YH; Sun WZ
    Acta Anaesthesiol Taiwan; 2006 Mar; 44(1):51-3. PubMed ID: 16623410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diet and growth of children with glycogen storage disease Types I and III.
    Daeschel IE; Janick LS; Kramish MJ; Coleman RA
    J Am Diet Assoc; 1983 Aug; 83(2):135-41. PubMed ID: 6409953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of glycogen storage disease type I associated with an incomplete type of Fanconi syndrome; the protective role of lysosomal alpha 1,4-glucosidase and insulin deficiency against hypoglycemia.
    Itakura M; Yamashita N; Fujita T; Koide Y; Kugai N; Yamamura H; Yamashita K
    Horm Metab Res; 1984 Dec; 16 Suppl 1():204-6. PubMed ID: 6398262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anesthetic management of a child with moyamoya disease combined with von Gierke's disease].
    Takeuchi M; Nohmi T; Ichikawa M; Ohnishi Y
    Masui; 2010 Feb; 59(2):260-3. PubMed ID: 20169974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary metabolic changes in von Gierke's disease (Type I glycogen storage disease).
    Blackett PR
    Ann Clin Lab Sci; 1982; 12(5):424-30. PubMed ID: 6753728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy and von Gierke's disease.
    Farber M; Knuppel RA; Binkiewicz A; Kennison RD
    Obstet Gynecol; 1976 Feb; 47(2):226-8. PubMed ID: 1061911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of glycogen storage disease (Von Gierke's disease).
    Spellberg MA
    Am J Gastroenterol; 1969 Jul; 52(1):45-7. PubMed ID: 5256253
    [No Abstract]   [Full Text] [Related]  

  • 11. Simultaneous liver-kidney transplantation for glycogen storage disease type IA (von Gierke's disease).
    Panaro F; Andorno E; Basile G; Morelli N; Bottino G; Fontana I; Bertocchi M; DiDomenico S; Miggino M; Saltalamacchia L; Ghinolfi D; Bonifazio L; Jarzembowski TM; Valente U
    Transplant Proc; 2004 Jun; 36(5):1483-4. PubMed ID: 15251364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Continuous nocturnal intragastric feeding in glycogenosis type I and III].
    de Parscau L; Guibaud P; Hermier M; François R
    Pediatrie; 1986; 41(3):197-203. PubMed ID: 3095784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Carbohydrates in the treatment of glycogenoses].
    Hayde M; Widhalm K
    Infusionstherapie; 1990 Apr; 17(2):69-72. PubMed ID: 2113038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic control of von Gierke disease (glycogen storage disease type Ia) in pregnancy: maintenance of euglycemia with cornstarch.
    Johnson MP; Compton A; Drugan A; Evans MI
    Obstet Gynecol; 1990 Mar; 75(3 Pt 2):507-10. PubMed ID: 2304723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biotin deficiency in a glycogen storage disease type 1b girl fed only with glycogen storage disease-related formula.
    Ihara K; Abe K; Hayakawa K; Makimura M; Kojima-Ishii K; Hara T
    Pediatr Dermatol; 2011; 28(3):339-41. PubMed ID: 21371115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia.
    Koeberl DD; Sun BD; Damodaran TV; Brown T; Millington DS; Benjamin DK; Bird A; Schneider A; Hillman S; Jackson M; Beaty RM; Chen YT
    Gene Ther; 2006 Sep; 13(17):1281-9. PubMed ID: 16672983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Present-day status of glycogenosis Ib. Report of a new case].
    Morena Hinojosas V; Fullana Montoro A; Alvarez-Coca González J; González Pérez-Venero M; Gracia Bouthelier R; Peralta Serrano A; Benlloch Marín T; Fontán Casariego G
    An Esp Pediatr; 1988 Jun; 28(6):557-60. PubMed ID: 3195858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid ethanol elimination in patients with type I glycogen storage disease is an adaptive change resulting from recurrent hypoglycemia.
    Greene HL; Parker PH; Hoyumpa AM; Hall SD
    J Lab Clin Med; 1986 Feb; 107(2):118-22. PubMed ID: 3456005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Von Gierke's disease: a review.
    Spahr RC
    South Med J; 1976 Aug; 69(8):1022-8. PubMed ID: 183291
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of continuous glucose therapy begun in infancy on the long-term clinical course of patients with type I glycogen storage disease.
    Wolfsdorf JI; Crigler JF
    J Pediatr Gastroenterol Nutr; 1999 Aug; 29(2):136-43. PubMed ID: 10435649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.